Advancing next-generation sequencing access: aspirations for next-generation sequencing policy and patient access in Hong Kong
- PMID: 40506245
- DOI: 10.12809/hkmj255177
Advancing next-generation sequencing access: aspirations for next-generation sequencing policy and patient access in Hong Kong
Conflict of interest statement
MCS Wong is an honorary medical advisor of GenieBiome Ltd, SunRise, and BGI Health. He is a member of the advisory committee for Pfizer; an external expert for GlaxoSmithKline Ltd; a member of the advisory board of AstraZeneca; and has received consultancy fees for providing research advice. As an editor of the journal, he was not involved in the internal review process prior to acceptance. Other authors disclose no conflicts of interest.
Publication types
LinkOut - more resources
Full Text Sources
